Technical Trade Alerts on Recent Analyst Upgrade Notables: IVGN, DENN, POT, NOK, CP, MF
Positive upgrades mostly drove bullish moves for several companies spanning numerous industries including biotechnology, restaurants, agricultural chemical, communications, railroads and financial companies.
(EMAILWIRE.COM, October 31, 2008 ) DALLAS, Texas – Beacon Equity Research announces the release of Trade Alerts covering recent analyst upgrades: Invitrogen Corp. (Nasdaq: IVGN), Denny’s Corp. (Nasdaq: DENN), Potash Corp. of Saskatchewan Inc. (NYSE: POT), Nokia Corp. (NYSE: NOK), Canadian Pacific Railway Ltd. (NYSE: CP) and MF Global Ltd. (NYSE: MF).
In the Trade Alert, the author highlights Invitrogen’s Buy rating, and shareholders vote to approve merger with Applied Biosystems Inc.:
“Invitrogen Corp. (IVGN) shares climbed 2.53% to $27.59 Thursday mid-day. Invitrogen engages in the development, manufacture and marketing of research tools in reagent, kit and applications forms for the life sciences research, drug discovery and diagnostics customers, as well as biological products manufacturers. … Deutsche Bank recently upgraded Invitrogen to Buy. … Invitrogen recently announced its shareholders have voted to approve the company’s proposed $6.4 billion merger with Applied Biosystems Inc. at a recent special shareholders' meeting. The company agreed to buy Applied Biosystems in June for $38 per share in cash and stock. Both companies said more than 80% of their shareholders voted in favor of the deal, which will combine the companies under the Applied Biosystems name.”
The Trade Alert author also featured Denny's upgrade to Buy, as well as a doubling in the company’s Q3 profits:
“Denny's Corp. (DENN) shares soared 9.74% Thursday mid-day, trading at $1.69. Denny's, through its subsidiaries, engages in the ownership and operation of family-style restaurants primarily in the United States. … Merriman Curhan recently upgraded Denny's from Neutral to Buy. … Denny's recently reported its profit more than doubled in the third quarter. For the quarter ended September 24, the company said its net income increased to $10.6 million, or 11 cents per share, up from $5 million, or 5 cents per share, during the prior year. Analysts polled by Thomson Reuters expected the company to earn 7 cents per share for the quarter.”
Investors can view all of the TraderNotes and investment articles for free by visiting:
http://www.beaconequity.com/m
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com
Beacon Equity Research Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
BeaconEquity.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
In the Trade Alert, the author highlights Invitrogen’s Buy rating, and shareholders vote to approve merger with Applied Biosystems Inc.:
“Invitrogen Corp. (IVGN) shares climbed 2.53% to $27.59 Thursday mid-day. Invitrogen engages in the development, manufacture and marketing of research tools in reagent, kit and applications forms for the life sciences research, drug discovery and diagnostics customers, as well as biological products manufacturers. … Deutsche Bank recently upgraded Invitrogen to Buy. … Invitrogen recently announced its shareholders have voted to approve the company’s proposed $6.4 billion merger with Applied Biosystems Inc. at a recent special shareholders' meeting. The company agreed to buy Applied Biosystems in June for $38 per share in cash and stock. Both companies said more than 80% of their shareholders voted in favor of the deal, which will combine the companies under the Applied Biosystems name.”
The Trade Alert author also featured Denny's upgrade to Buy, as well as a doubling in the company’s Q3 profits:
“Denny's Corp. (DENN) shares soared 9.74% Thursday mid-day, trading at $1.69. Denny's, through its subsidiaries, engages in the ownership and operation of family-style restaurants primarily in the United States. … Merriman Curhan recently upgraded Denny's from Neutral to Buy. … Denny's recently reported its profit more than doubled in the third quarter. For the quarter ended September 24, the company said its net income increased to $10.6 million, or 11 cents per share, up from $5 million, or 5 cents per share, during the prior year. Analysts polled by Thomson Reuters expected the company to earn 7 cents per share for the quarter.”
Investors can view all of the TraderNotes and investment articles for free by visiting:
http://www.beaconequity.com/m
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com
Beacon Equity Research Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
BeaconEquity.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Contact Information:
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:
stock market, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, invitrogen corp., denny's corp., potash corp., saskatchewan inc., nikia corp., canadian pacific railway ltd., mf global ltd
stock market, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, invitrogen corp., denny's corp., potash corp., saskatchewan inc., nikia corp., canadian pacific railway ltd., mf global ltd
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |